Franklin Resources
AERI

Franklin Resources’s Aerie Pharmaceuticals AERI Stock Holding History

Franklin Resources’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,210,766
Closed -$14.3M – 1968
2020
Q3 		$14.3M Buy
1,210,766
+36,966
+3% +$450K 0.01% 844
2020
Q2 		$15.6M Hold
1,173,800
– – 0.01% 795
2020
Q1 		$15.8M Buy
1,173,800
+30,500
+3% +$579K 0.01% 720
2019
Q4 		$27.6M Buy
+1,143,300
New +$23.7M 0.01% 692

Other funds holding AERI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CWG
C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Franklin Resources's AERI Position: Q4 2020 in Review

Franklin Resources sold out of Aerie Pharmaceuticals (AERI) in Q4 2020, closing a stake of 1,210,766 shares — an estimated $14.3M sold.

Franklin Resources first reported a position in AERI in Q4 2019 and held it in 4 quarters. The position peaked at $27.6M in Q4 2019. 150 funds tracked by Wall St. Rank hold AERI as of Q4 2020.

  • Franklin Resources reported no remaining Aerie Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Franklin Resources sold 1,210,766 Aerie Pharmaceuticals shares in Q4 2020, an estimated $14.3M.
  • Franklin Resources first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 4 quarters.
  • Franklin Resources's Aerie Pharmaceuticals position peaked at $27.6M in Q4 2019.
  • 150 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2020.

Based on Franklin Resources's 13F filing for Q4 2020, filed 10 Feb 2021.